Medical News

RSS

SINTEF ICT scientists develop sensor belt to monitor chronically ill patients

SINTEF ICT scientists have developed a sensor belt that monitors chronically ill patients and communicates the results via mobile telephone. The scientists are now about to carry out a user trial together with a research partner in the US.

14 Dec 2010

Reversible two-step binding mechanism to stop cancer cell growth

What makes cancer cells so dangerous is that they grow in an unregulated way and proliferate much faster than other cells. The proteasome, a large protein complex, plays a key role in this process: By breaking down used proteins for recycling, it clears the way for the next cycle.

14 Dec 2010

Go Daddy gifts $500,000 to Southwest Center for HIV/AIDS to launch Women's Health Center in Phoenix

Southwest Center for HIV/AIDS received $500,000 from Go Daddy to launch the Go Daddy Women's Health Center in Phoenix. The gift was announced by Go Daddy CEO and Founder Bob Parsons at the company's annual holiday event held Saturday, December 11 at Chase Field in Phoenix. Parsons presented a 'big check' to Carol Poore, President and CEO, Southwest Center for HIV/AIDS.

14 Dec 2010

Study finds expression of toxic RNA that leads to Fragile X Tremor Ataxia Syndrome modifiable

Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.

14 Dec 2010

National Institutes of Health honors Nevada nursing professor with $377,000 for ischemia study

University of Nevada, Reno Orvis School of Nursing researcher Michele Pelter has been awarded $377,000 from the National Institutes of Health to study detection of ischemia, a condition that can lead to heart attacks.

14 Dec 2010

Osteoporosis drug reduces bone loss in oral cancer

A drug currently approved for osteoporosis treatment has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as an important supplemental therapy in patients with head and neck cancers that erode bone.

14 Dec 2010

UCSF physicians evlaute devices that could reduce hair loss in breast cancer patients undergoing chemotherapy

UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- "Hair to Stay" -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.

14 Dec 2010

Senator Leahy calls for U.S. to suspend direct aid to Haiti's government, visas for Haitian officials

Senator Patrick Leahy (D-Vt.), who chairs the Senate Appropriations Committee's Subcommittee on the State, Foreign Operations, and Related Programs, "on Friday urged President Barack Obama's administration to suspend direct aid to Haiti's government and visas for its top officials until it ensures a fair and democratic outcome to disputed national elections," Reuters reports.

14 Dec 2010

Mouse study shows flu virus infection may protect against asthma

In a paper that suggests a new strategy to prevent asthma, scientists at Children's Hospital Boston and their colleagues report that the influenza virus infection in young mice protected the mice as adults against the development of allergic asthma.

14 Dec 2010

Drug to reverse immunological decline in aging

UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.

14 Dec 2010

Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles

Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.

14 Dec 2010

Novel labeling technique helps researchers to explore DNA chemical modification

Researchers at Emory University School of Medicine and the University of Chicago have developed a method for labeling and mapping a "sixth nucleotide," whose biological role scientists are only beginning to explore.

14 Dec 2010

Underwriters partially exercise over-allotment option in Cadence public offering

Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.

14 Dec 2010

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Access Community Health Network (ACCESS) has received a $6.7 million Clinical and Translational Science Award grant from the National Institutes of Health (NIH) to construct a community-based research center. The goal of the center's research will be to engage the community and reduce racial and ethnic disparities in health care.

14 Dec 2010

Hospital de Clinicas de Niteroi to acquire Samaritano

Amilpar, the largest healthcare company in Brazil, in accordance with CVM Instruction 358, of January 3, 2002, informs that the Hospital de Clinicas de Niteroi Ltda. ("HCN"), a company owned by our indirect controlling shareholder, has signed an Agreement to acquire up to 100% of the shares representatives of the capital stock of Hospital Samaritano ("Samaritano") for the total amount of R$ 180 million.

14 Dec 2010

Capstone presents AZX100 Phase 2a trial results for keloid and trocar site scarring

Capstone Therapeutics announced today twelve-month results from its two AZX100 Phase 2a pilot clinical trials in keloid scarring and seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.

14 Dec 2010

BUSM professor wins 2010 Van Slyke Award for seminal contributions to laboratory medicine

Michael F. Holick, PhD, MD, a professor at Boston University School of Medicine (BUSM), is the recipient of the 2010 Van Slyke Award from the American Academy for Clinical Chemistry New York Metro Section.

14 Dec 2010

FOXA1 gene controls oestrogen-fuelled growth of breast cancer cells

CANCER RESEARCH UK scientists have discovered that a single gene controls the oestrogen-fuelled growth of breast cancer cells, according to research published in Nature Genetics on Sunday.

14 Dec 2010

EU, India talks end with resolution on drug seizures, little progress on free trade agreement

"The European Union and India resolved a dispute over generic drugs on Friday which should remove obstacles to Indian drugs manufacturers exporting products to the developing world, officials said," Reuters reports in an article that describes the customs regulations previously in place that led "to numerous seizures of generic drugs shipments in transit from India to countries in South America via Europe."

14 Dec 2010

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental New Drug Application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension for use in stress echocardiography.

14 Dec 2010

Medical News

SINTEF ICT scientists develop sensor belt to monitor chronically ill patients

Reversible two-step binding mechanism to stop cancer cell growth

Go Daddy gifts $500,000 to Southwest Center for HIV/AIDS to launch Women's Health Center in Phoenix

Study finds expression of toxic RNA that leads to Fragile X Tremor Ataxia Syndrome modifiable

National Institutes of Health honors Nevada nursing professor with $377,000 for ischemia study

Osteoporosis drug reduces bone loss in oral cancer

UCSF physicians evlaute devices that could reduce hair loss in breast cancer patients undergoing chemotherapy

Senator Leahy calls for U.S. to suspend direct aid to Haiti's government, visas for Haitian officials

Mouse study shows flu virus infection may protect against asthma

Drug to reverse immunological decline in aging

Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles

Novel labeling technique helps researchers to explore DNA chemical modification

Underwriters partially exercise over-allotment option in Cadence public offering

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Hospital de Clinicas de Niteroi to acquire Samaritano

Capstone presents AZX100 Phase 2a trial results for keloid and trocar site scarring

BUSM professor wins 2010 Van Slyke Award for seminal contributions to laboratory medicine

FOXA1 gene controls oestrogen-fuelled growth of breast cancer cells

EU, India talks end with resolution on drug seizures, little progress on free trade agreement

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News